ALPS Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

ALPS Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-85,462	Closed	-$265K	–	1042
2021 Q4	$265K	Buy	85,462 +1,710	+2%	+$5.75K	﹤0.01%	854
2021 Q3	$302K	Sell	83,752 -6,219	-7%	-$23.5K	﹤0.01%	860
2021 Q2	$322K	Hold	89,971	–	–	﹤0.01%	793
2021 Q1	$352K	Buy	+89,971	New	+$372K	﹤0.01%	577
2015 Q4	–	Sell	-82,025	Closed	-$4.56K	–	718
2015 Q3	$4.56K	Buy	82,025 +30,064	+58%	+$222K	﹤0.01%	565
2015 Q2	$414K	Buy	51,961 +26,509	+104%	+$228K	﹤0.01%	624
2015 Q1	$267K	Buy	+25,452	New	+$348K	﹤0.01%	629

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

ALPS Advisors's BDSI Position: Q1 2022 in Review

ALPS Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 85,462 shares — an estimated $265K sold.

ALPS Advisors first reported a position in BDSI in Q1 2015 and held it in 7 quarters. The position peaked at $414K in Q2 2015. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

ALPS Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
ALPS Advisors sold 85,462 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $265K.
ALPS Advisors first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 7 quarters.
ALPS Advisors's BioDelivery Sciences International, Inc. position peaked at $414K in Q2 2015.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on ALPS Advisors's 13F filing for Q1 2022, filed 16 May 2022.